SD Biosensor - Public Comps and Valuation Multiples

SD Biosensor Overview

About SD Biosensor

SD Biosensor Inc is an in vitro diagnostic company. It aims to contribute to the improvement of quality of life through rapid and accurate disease diagnosis. It is researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, blood glucose monitoring systems for self -testing.

Founded

1999

HQ

Employees

n/a

Website

sdbiosensor.co.in

Sectors

Medical Devices
DeepTech
HealthTech

Financials

Last FY Revenue $471M

Last FY EBITDA -$6.0M

EV

$564M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

SD Biosensor Financials

See SD Biosensor valuation multiples based on analyst estimates

SD Biosensor P&L

In the most recent fiscal year, SD Biosensor reported revenue of $471M and EBITDA of -$6.0M.

SD Biosensor expects next 12-month revenue of XXX and NTM EBITDA of XXX

See SD Biosensor valuation multiples based on analyst estimates

	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	XXX	$471M	XXX	XXX	XXX
Gross Profit	XXX	$230M	XXX	XXX	XXX
Gross Margin	XXX	49%	XXX	XXX	XXX
EBITDA	XXX	-$6.0M	XXX	XXX	XXX
EBITDA Margin	XXX	-1%	XXX	XXX	XXX
EBIT	XXX	-$36.6M	XXX	XXX	XXX
EBIT Margin	XXX	-8%	XXX	XXX	XXX
Net Profit	XXX	-$66.7M	XXX	XXX	XXX
Net Margin	XXX	-14%	XXX	XXX	XXX
Net Debt	XXX	$277M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for SD Biosensor including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, SD Biosensor achieved $471M in revenue and -$6.0M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	Analyst estimates available to subscribers	$471M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$230M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	48.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	-$6.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	-1.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	-$36.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	-7.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	-$66.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	-14.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$277M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for SD Biosensor

This financial data table provides comprehensive performance metrics for SD Biosensor, a company based in South Korea. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, SD Biosensor reported $471M in total revenue.
Fiscal year EBITDA was -$6.0M.
The company maintained a gross profit margin of 48.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was -1.3%.
Net profit margin reached -14.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for SD Biosensor. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

SD Biosensor Stock Performance

SD Biosensor has current market cap of KRW 983B (or $666M), and EV of KRW 832B (or $564M).

Market Cap Evolution

SD Biosensor Stock Data

As of January 19, 2026, SD Biosensor's stock price is KRW 8220 (or $6).

See SD Biosensor trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$564M	$666M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

SD Biosensor Valuation Multiples

SD Biosensor's trades at 1.2x EV/Revenue multiple, and -93.4x EV/EBITDA.

See valuation multiples for SD Biosensor and 15K+ public comps

SD Biosensor Financial Valuation Multiples

As of January 19, 2026, SD Biosensor has market cap of $666M and EV of $564M.

Equity research analysts estimate SD Biosensor's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

SD Biosensor's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$666M	XXX	$666M	XXX	XXX	XXX
EV (current)	$564M	XXX	$564M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	1.2x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-93.4x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-15.4x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-10.0x	XXX	XXX	XXX
EV/FCF	n/a	XXX	11.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get SD Biosensor Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

SD Biosensor Margins & Growth Rates

SD Biosensor's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

SD Biosensor's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

SD Biosensor's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for SD Biosensor and other 15K+ public comps

SD Biosensor Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	9%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	13%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	57%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial